Expert Q&A Presentations

Insulin Replacement Therapy 2019: Evolving Treatments and their Clinical Implications


Presentations


Speakers

  • Alissa R. Segal, PharmD, CDE, CDTC, FCCP

    Alissa R. Segal, PharmD, CDE, CDTC, FCCP

    Alissa R. Segal, PharmD, CDE, CDTC, FCCP

    Clinical Pharmacist and Diabetes Educator

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician; Medical Director, Continuing Medical Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Martin J. Abrahamson, MD, FACP

    Martin J. Abrahamson, MD, FACP

    Martin J. Abrahamson, MD, FACP

    Associate Professor of Medicine

    Dr. Abrahamson is Associate Professor of Medicine at Harvard Medical School and Medical Director at the Joslin Diabetes Center in Boston, Massachusetts. He co-directs the Joslin – Beth Israel Deaconess Medical Center (BIDMC) Diabetes-Heart Program, a joint venture between Joslin Clinic and the Division of Cardiology at BIDMC. At Beth Israel Deaconess Medical Center, Dr. Abrahamson also serves as Director of the Division of Continuing Medical Education in the Department of Medicine. At Joslin Clinic, Dr. Abrahamson is credited with reorganizing the Adult Diabetes Section into multidisciplinary teams comprised of physicians, nurse practitioners, nurse educators, nutritionists, and exercise physiologists. He is spearheading “pathways of care” for patients referred to Joslin (JoslinCare), has co-authored guidelines for both the pharmacological and perioperative management of patients with diabetes and management of hyperglycemic emergencies, and has authored more than 50 papers, review articles and chapters related to diabetes. He received his medical degree from University of Cape Town in Cape Town, South Africa, and completed his internship and residency in internal medicine and endocrinology at Groote Schuur Hospital, also in Cape Town, where he was a research fellow before joining the faculty of medicine at the University of Cape Town and Groote Schuur Hospital. Dr. Abrahamson was joint head of the endocrine unit in Cape Town before taking up a faculty appointment at Harvard Medical School and Beth Israel Hospital in 1992. Dr. Abrahamson’s research interests include evaluation of the efficacy and utility of a continuous glucose monitoring sensors in the management of patients with diabetes, and prevalence of silent coronary ischemia in patients with diabetes. Dr. Abrahamson is board certified in internal medicine and in endocrinology, diabetes and metabolism, and is a Fellow of the College of Physicians of South Africa.